publication venue for
- Neutrophil-mediated innate immune resistance to bacterial pneumonia is dependent on Tet2 function. 134:e171002. 2024
- Spliceosome malfunction causes neurodevelopmental disorders with overlapping features. 134:e171235. 2024
- HDACi promotes inflammatory remodeling of the tumor microenvironment to enhance epitope spreading and antitumor immunity. 132:e159283. 2022
- Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes. 132:e156125. 2022
- Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses. 131:146922. 2021
- Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology. 131:1-22. 2021
- Biomarkers of inflammation and repair in kidney disease progression. 131:139927. 2021
- Normal and defective pathways in biogenesis and maintenance of the insulin storage pool. 131:142240. 2021
- The loss-of-function PCSK9Q152H variant increases ER chaperones GRP78 and GRP94 and protects against liver injury. 131:128650. 2021
- The landscape of RNA polymerase II–associated chromatin interactions in prostate cancer. 130:3987-4005. 2020
- Panic prescribing has become omnipresent during the COVID-19 pandemic. 130:2752-2753. 2020
- Endogenous T cells prevent tumor immune escape following adoptive T cell therapy. 129:5400-5410. 2019
- Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. 129:3171-3184. 2019
- Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy. 129:1240-1256. 2019
- Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity. 129:518-530. 2018
- Tie2 protects the vasculature against thrombus formation in systemic inflammation. 128:1471-1484. 2018
- MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. 125:4334-4348. 2015
- IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. 125:3766-3781. 2015
- Plasma fibronectin supports hemostasis and regulates thrombosis. 124:4281-4293. 2014
- Compromised genomic integrity impedes muscle growth after Atrx inactivation. 122:4412-4423. 2012
- HERV-K–specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. 122:4473-4489. 2012
- Blood flow reprograms lymphatic vessels to blood vessels. 122:2006-2017. 2012
- Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. 121:4903-4915. 2011
- The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies. 121:4537-4547. 2011
- Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8–mediated activation of TGF-β. 121:2863-2875. 2011
- Shank-interacting protein–like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. 120:2094-2108. 2010
- Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer. 119:1093-1108. 2009
- VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. 119:1298-1311. 2009
- Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. 118:2209-2218. 2008
- Complex two-gene modulation of lung disease severity in children with cystic fibrosis. 118:1040-1049. 2008
- Complex two-gene modulation of lung disease severity in children with cystic fibrosis. 118:1040-1049. 2008
- Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. 114:1774-1781. 2004
- Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes. 114:1774-1781. 2004
- Tregs and allergic disease. 114:1389-1397. 2004
- Tregs and allergic disease. 114:1389-1397. 2004
- TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. 113:401-413. 2004
- TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. 113:401-413. 2004
- The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. 112:58-66. 2003
- The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. 112:58-66. 2003
- Heparan sulfate: Antithrombotic or not?. 111:952-954. 2003
- Heparan sulfate: Antithrombotic or not?. 111:952-954. 2003
- Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. 111:479-486. 2003
- Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. 111:479-486. 2003
- Generation of experimental allergic airways inflammation in the absence of draining lymph nodes. 108:577-583. 2001
- Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis. 107:1529-1536. 2001
- Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. 107:1263-1273. 2001
- Enhanced intestinal transepithelial antigen transport in allergic rats is mediated by IgE and CD23 (FcεRII). 106:879-886. 2000
- IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. 105:1697-1710. 2000
- Macrophages are a significant source of type 1 cytokines during mycobacterial infection. 103:1023-1029. 1999
- GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice.. 102:1704-1714. 1998
- Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.. 102:1132-1141. 1998
- Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds.. 101:2497-2505. 1998
- Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice.. 101:1342-1353. 1998
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.. 101:311-320. 1998
- Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease.. 100:2766-2776. 1997
- Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation.. 100:2466-2475. 1997
- Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung.. 100:768-776. 1997
- Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.. 99:106-109. 1997
- CD40 expression by human peripheral blood eosinophils.. 97:1761-1766. 1996
- Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.. 97:1122-1128. 1996
- Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions.. 97:1102-1110. 1996
- Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.. 97:826-832. 1996
- A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.. 97:196-201. 1996
- Hyper IgM syndrome associated with defective CD40-mediated B cell activation.. 94:1404-1409. 1994
- Behavioral consequences of bone marrow transplantation in the treatment of murine mucopolysaccharidosis type VII.. 94:1180-1186. 1994
- Systemic administration of ciliary neurotrophic factor induces cachexia in rodents.. 93:2632-2638. 1994
- Anchorage-independent colony growth of pulmonary fibroblasts derived from fibrotic human lung tissue.. 93:1525-1532. 1994
- Depletion of OX-8 lymphocytes from the blood and airways using monoclonal antibodies enhances the late airway response in rats.. 92:1477-1482. 1993
- Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.. 92:1580-1586. 1993
- Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs.. 92:315-323. 1993
- Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line.. 91:2630-2639. 1993
- Alpha 2-antiplasmin supplementation inhibits tissue plasminogen activator-induced fibrinogenolysis and bleeding with little effect on thrombolysis.. 91:1343-1350. 1993
- An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.. 91:1138-1148. 1993
- Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1).. 89:1662-1668. 1992
- Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.. 89:766-773. 1992
- An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.. 89:321-326. 1992
- Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.. 87:1082-1090. 1991
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.. 86:385-391. 1990
- Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.. 86:203-212. 1990
- Pathophysiology of rhinitis. Lactoferrin and lysozyme in nasal secretions.. 84:1528-1535. 1989
- Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.. 82:1700-1707. 1988
- Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes.. 79:1204-1209. 1987
- Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency.. 78:155-162. 1986
- Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.. 77:645-648. 1986
- Immune-mediated thrombocytopenia of malaria.. 71:832-836. 1983
- Reversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaproic acid.. 71:159-164. 1983
- A molecular defect in two families with hemolytic poikilocytic anemia: reduction of high affinity membrane binding sites for ankyrin.. 68:1566-1576. 1981
- Basophil Production. 65:390-399. 1980
- Shortening of the Bleeding Time in Rabbits by Hydrocortisone Caused by Inhibition of Prostacyclin Generation by the Vessel Wall. 63:1026-1035. 1979
- Thrombogenic Effect of High-Dose Aspirin in Rabbits. 62:892-895. 1978
- The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.. 60:1191-1201. 1977
- Resolution of Experimental Pulmonary Emboli with Heparin and Streptokinase in Different Dosage Regimens. 54:782-791. 1974
- Altered sulfhydryl reactivity of hemoglobins and red blood cell membranes in congenital heinz body hemolytic anemia. 47:2664-2677. 1968
- The effect of platelet age on platelet adherence to collagen. 47:466-473. 1968
- Steady state measurement of regional ventilation to perfusion ratios in normal man.. 45:1349-1356. 1966